Flare Capital Partners — 2021 Investments
4 investments dated 2021 · listed companies and verified rows first · show all
HealthVerity operates a healthcare and consumer data ecosystem that enables HIPAA-compliant synchronization and exchange of real-world data across pharma, payers, and government agencies.
Data & InfrastructureEnterprise SoftwareHealthtechPhiladelphia, US
Andrew Kress(Co-Founder and CEO)inAndrew Goldberg(Co-Founder and COO)
BoardRachel Winokur(Director)
Board seatMichael Greeley· per SEC Form D
Co-investorsForesite CapitalGreycroftNew Enterprise Associates (NEA)
Somatus provides value-based, integrated kidney care and a congestive heart failure management solution for patients, providers, and health plan partners.
Digital HealthHealthtechMclean, US
Ikenna Okezie(Executive Officer, Director)Alexander Houlday(Executive Officer)Stacey Queen-Pyndell(Executive Officer)
BoardAnna Haghgooie(Director)Anthony Welters(Director)
Board seatDan Gebremedhin· per SEC Form D
Co-investorsOptum VenturesHealthQuest CapitalBlue Venture FundsDefy PartnersLongitude CapitalRA Capital+4 more
Cohere Health provides a platform aimed at aligning the interests of patients, physicians, and health plans to support care decisions and improve member outcomes.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSBoston, US
Siva Namasivayam(Executive Officer, Director)Robert Shepardson(Executive Officer)Kristen Carucci(Executive Officer)Duncan Reese(Executive Officer)
BoardDavid Barrett(Director)Amir Debourou(Director)
Board seatGary GottliebMichael Greeley· per SEC Form D
Co-investorsCota CapitalLongitude CapitalDeerfield Management CompanyDefine VenturesFlare Capital StrategiesTemasek
New York, US
Scott Luke Sansovich Jr.(Executive Officer, Director)Matthew Johnson McCambridge(Executive Officer, Director)Scott Sansovich(Founder)in
BoardBenjamin Stein(Director)
Board seatDan Gebremedhin· per SEC Form D
Co-investorsAcrew CapitalPJC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.